The purpose of this research study is to investigate brain changes in adolescents who are currently experiencing ADHD symptoms. Participants will be given mixed amphetamine salts for a 12-week treatment period. 


Adolescents 13 to17 years of age who are experiencing ADHD symptoms or have been diagnosed with ADHD. 


Participants will receive compensation for their transportation and/or time for study visits. All study visits, tests, procedures and medication will be provided at no cost to participants. 


Participants will have MRI scans. For more information,contact Laura McLaughlin at laura.mclaughlin@uc.edu or call 513-558-6205.